First Time Loading...

Huadong Medicine Co Ltd
SZSE:000963

Watchlist Manager
Huadong Medicine Co Ltd Logo
Huadong Medicine Co Ltd
SZSE:000963
Watchlist
Price: 32.94 CNY -0.09%
Updated: May 2, 2024

Huadong Medicine Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huadong Medicine Co Ltd
Operating Income Peer Comparison

Comparables:
1099
S
601607
600998
C
600511
C
000028

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
¥3.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
15%
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
¥22.9B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
16%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
¥8.9B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
¥3.9B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
18%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
¥2.4B
CAGR 3-Years
16%
CAGR 5-Years
5%
CAGR 10-Years
21%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Operating Income
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
12%

See Also

What is Huadong Medicine Co Ltd's Operating Income?
Operating Income
3.7B CNY

Based on the financial report for Sep 30, 2023, Huadong Medicine Co Ltd's Operating Income amounts to 3.7B CNY.

What is Huadong Medicine Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
15%

Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Huadong Medicine Co Ltd have been 5% over the past three years , 6% over the past five years , and 15% over the past ten years .